123 related articles for article (PubMed ID: 33785416)
1. The effect of hypergravity in intestinal permeability of nanoformulations and molecules.
Azevedo C; Macedo MH; Almeida A; Pinto S; van Loon JJWA; Sarmento B
Eur J Pharm Biopharm; 2021 Jun; 163():38-48. PubMed ID: 33785416
[TBL] [Abstract][Full Text] [Related]
2. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
3. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
4. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574
[TBL] [Abstract][Full Text] [Related]
5. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
Wu SJ; Don TM; Lin CW; Mi FL
Mar Drugs; 2014 Nov; 12(11):5677-97. PubMed ID: 25421323
[TBL] [Abstract][Full Text] [Related]
6. Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected].
Dittmann I; Amasheh M; Krug SM; Markov AG; Fromm M; Amasheh S
Pharm Res; 2014 Sep; 31(9):2539-48. PubMed ID: 24633418
[TBL] [Abstract][Full Text] [Related]
7. Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion.
Takizawa Y; Kishimoto H; Kitazato T; Tomita M; Hayashi M
Int J Pharm; 2012 Apr; 426(1-2):82-89. PubMed ID: 22285474
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
9. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
11. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
12. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
13. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells.
Kowapradit J; Opanasopit P; Ngawhirunpat T; Rojanarata T; Ruktanonchai U; Sajomsang W
Drug Deliv; 2010 Jul; 17(5):301-12. PubMed ID: 20302396
[TBL] [Abstract][Full Text] [Related]
14. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
[TBL] [Abstract][Full Text] [Related]
15. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
16. Absorption-Enhancing Mechanisms of Capryol 90, a Novel Absorption Enhancer, for Improving the Intestinal Absorption of Poorly Absorbed Drugs: Contributions to Trans- or Para-Cellular Pathways.
Ukai H; Imanishi A; Kaneda A; Kimura E; Koyama M; Morishita M; Katsumi H; Yamamoto A
Pharm Res; 2020 Nov; 37(12):248. PubMed ID: 33230672
[TBL] [Abstract][Full Text] [Related]
17. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
18. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
19. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
[TBL] [Abstract][Full Text] [Related]
20. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions.
Putt KK; Pei R; White HM; Bolling BW
Food Funct; 2017 Jan; 8(1):406-414. PubMed ID: 28091645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
